State of Wyoming’s Ocular Therapeutix OCUL Stock Holding History

State of Wyoming’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,403	Closed	-$77.7K	–	1969
2025 Q4	$77.7K	Buy	+6,403	New	+$77.8K	0.01%	1362
2025 Q1	–	Sell	-1,049	Closed	-$8.96K	–	1786
2024 Q4	$8.96K	Buy	+1,049	New	+$10.2K	﹤0.01%	1537
2023 Q3	–	Sell	-462	Closed	-$2.38K	–	1748
2023 Q2	$2.38K	Buy	+462	New	+$2.75K	﹤0.01%	1501
2022 Q4	–	Sell	-9,740	Closed	-$40K	–	1708
2022 Q3	$40K	Buy	+9,740	New	+$49.1K	0.02%	1096

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State of Wyoming's OCUL Position: Q1 2026 in Review

State of Wyoming sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 6,403 shares — an estimated $77.7K sold.

State of Wyoming first reported a position in OCUL in Q3 2022 and held it in 4 quarters. The position peaked at $77.7K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

State of Wyoming reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
State of Wyoming sold 6,403 Ocular Therapeutix shares in Q1 2026, an estimated $77.7K.
State of Wyoming first reported a position in Ocular Therapeutix in Q3 2022 and held it in 4 quarters.
State of Wyoming's Ocular Therapeutix position peaked at $77.7K in Q4 2025.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.